Center and OHSU Researchers Write on Nusinersen

Back to News & Reports

Two of the Center’s Clinical Epidemiologists, Martha Gerrity MD, MPH, PhD, and Adam Obley, MD, together with OHSU colleague Vinay Prasad, MD, MPH, recently contributed a Viewpoint column to the April 30, 2018 Journal of the American Medical Association Internal Medicine Titled “Concerns About the Approval of Nusinersen Sodium by the US Food and Drug Administration”.  The column raises important methodological concerns with the determinations of efficacy for this ambitious and expensive new drug.